Patent · US Active

Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators

US10550102B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Christopher M. Adams · Arlington, US
Doug Bevan · Chelmsford, US
Michael Paul Capparelli · Cambridge, US
Takeru Ehara · Tsukuba, JP
Luciana Ferrara · Stoughton, US
Nan Ji · Arlington, US
Erik Meredith · Cambridge, US
Muneto Mogi · Waltham, US
James J. Powers · Waltham, US
Ganesh Prasanna · Acton, US
Nello Mainolfi · Belmont, US
Mitsunori Kato · Cambridge, US

Key dates

Filing date	Dec 11, 2018
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Dec 11, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.